Genomic imprinting biomarkers for cervical cancer risk stratification

Xue Xiao; Wei Wang; Peng Bai; Ying Chen; Zhengwen Qin; Tong Cheng; Xing Li; John P. Pineda; Panying Shi; Xiaonan Wang; Jianhong Wang; Lian Xu; Xuemei Gao; Huixian Zheng; Lulu Yang; Wenyi Lin; Wenbin Huang; Rulong Shen; Changjun Yue; Huixiong Xu; Felipe Batalini; Yang Liu; Ning Zhou; Yaoyao Zhang; Hanmin Liu

doi:10.1002/cac2.12617

Cancer Communications ›› 2024, Vol. 44 ›› Issue (12) : 1385 -1390. DOI: 10.1002/cac2.12617

LETTER TO THE JOURNAL

Genomic imprinting biomarkers for cervical cancer risk stratification

Xue Xiao ¹^,²
, Wei Wang ²^,³
, Peng Bai ⁴
, Ying Chen ⁵
, Zhengwen Qin ⁶
, Tong Cheng ⁷^,⁸
, Xing Li ⁷
, John P. Pineda ⁷
, Panying Shi ⁷
, Xiaonan Wang ⁷
, Jianhong Wang ⁹
, Lian Xu ²^,³
, Xuemei Gao ¹^,²
, Huixian Zheng ⁶
, Lulu Yang ¹⁰
, Wenyi Lin ¹¹
, Wenbin Huang ¹²
, Rulong Shen ¹³
, Changjun Yue ¹⁴
, Huixiong Xu ¹⁵
, Felipe Batalini ¹⁶
, Yang Liu ¹⁷^,^†
, Ning Zhou ⁷^,⁸^,^†
, Yaoyao Zhang ¹^,²^,^†
, Hanmin Liu ²^,¹⁸^,^†

Author information +

¹. Department of Gynecology and Obstetrics,West China Second University Hospital, Sichuan University, Chengdu, Sichuan, P. R. China

². Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education,West China Second Hospital, Sichuan University, Chengdu, Sichuan, P. R. China

³. Department of Pathology,West China Second University Hospital, Sichuan University, Chengdu, Sichuan, P. R. China

⁴. Department of Forensic Genetics,West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, Sichuan, P. R. China

⁵. Department of Obstetrics and Gynecology, Chengdu Women’s and Children’s Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, P. R. China

⁶. Department of Gynecology, Zigong Maternity and Child Health Care Hospital, Zigong, Sichuan, P. R. China

⁷. Lisen Imprinting Diagnostics Wuxi, Ltd.,Wuxi, Jiangsu, P. R. China

⁸. Lisen Imprinting Diagnostics, Inc.,Wilmington, Delaware, USA

⁹. Department of Gynecology, Chengdu Chenghua District Maternal and Child Health Center, Chengdu, Sichuan, P. R. China

¹⁰. Department of Pathology, Nanjing First Hospital, Nanjing, Jiangsu, P. R. China

¹¹. Department of Pathology, Chengdu Women’s and Children’s Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, P. R. China

¹². Department of Pathology, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan, P. R. China

¹³. Department of Pathology, Ohio State University Wexner Medical Center, Columbus, Ohio, USA

¹⁴. Department of Pathology, Harbor-UCLA Medical Center, Torrance, California, USA

¹⁵. Department of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai, P. R. China

¹⁶. Division of Medical Oncology, Mayo Clinic Arizona, Phoenix, Arizona, USA

¹⁷. Department of Pathology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, Sichuan, P. R. China

¹⁸. Department of Pediatrics,West China Second University Hospital, Sichuan University, Chengdu, Sichuan, P. R. China

liuyanglyon@uestc.edu.cn

zhou.ning@lisenid.com

yaoyaozhang@scu.edu.cn

liuhm@scu.edu.cn

Show less

History +

PDF

Cite this article

Download citation ▾

Xue Xiao, Wei Wang, Peng Bai, Ying Chen, Zhengwen Qin, Tong Cheng, Xing Li, John P. Pineda, Panying Shi, Xiaonan Wang, Jianhong Wang, Lian Xu, Xuemei Gao, Huixian Zheng, Lulu Yang, Wenyi Lin, Wenbin Huang, Rulong Shen, Changjun Yue, Huixiong Xu, Felipe Batalini, Yang Liu, Ning Zhou, Yaoyao Zhang, Hanmin Liu. Genomic imprinting biomarkers for cervical cancer risk stratification. Cancer Communications, 2024, 44(12): 1385-1390 DOI:10.1002/cac2.12617

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]

Colposcopy and Cervical Neoplasia Committee-Chinese Obstetricians and Gynecologists Association, Chinese Journal of Health Management Editorial Committee, Lang J, Zeng Q. Expert consensus on application of HPV DNA test in screening cervical cancer in physical examination [HPV DNA jiance yingyong yu jiankang tijian renqun zigongjingai chushai de zhuanjia gongshi]. Chinese Journal of Health Management [Zhonghua Jiankang Guanlixue Zazhi]. 2022; 16(10): 665-672. [in Chinese].

[2]	Schmitz M, Eichelkraut K, Schmidt D, Zeiser I, Hilal Z, Tettenborn Z, et al. Performance of a DNA methylation marker panel using liquid-based cervical scrapes to detect cervical cancer and its precancerous stages. BMC Cancer. 2018; 18(1): 1197.

[3]	Bonde J, Floore A, Ejegod D, Vink FJ, Hesselink A, van de Ven PM, et al. Methylation markers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study. Int J Cancer. 2021; 148(2): 396-405.

[4]	Jelinic P, Shaw P. Loss of imprinting and cancer. J Pathol. 2007; 211(3): 261-268.

[5]	Shen R, Cheng T, Xu C, Yung RC, Bao J, Li X, et al. Novel visualized quantitative epigenetic imprinted gene biomarkers diagnose the malignancy of ten cancer types. Clin Epigenetics. 2020; 12(1): 71.

[6]	Murrell A. Genomic imprinting and cancer: from primordial germ cells to somatic cells. ScientificWorldJournal. 2006; 6: 1888-1910.

[7]	Uribe-Lewis S, Woodfine K, Stojic L, Murrell A. Molecular mechanisms of genomic imprinting and clinical implications for cancer. Expert Rev Mol Med. 2011; 13: e2.

[8]	Goovaerts T, Steyaert S, Vandenbussche CA, Galle J, Thas O, Van Criekinge W, et al. A comprehensive overview of genomic imprinting in breast and its deregulation in cancer. Nat Commun. 2018; 9(1): 4120.

[9]	Freeman JR, Chu S, Hsu T, Huang YT. Epigenome-wide association study of smoking and DNA methylation in non-small cell lung neoplasms. Oncotarget. 2016; 7(43): 69579-69591.

[10]	Arbyn M, Roelens J, Simoens C, Buntinx F, Paraskevaidis E, Martin-Hirsch PP. et al. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions. Cochrane Database Syst Rev. 2013; 2013(3): Cd008054.